← SynDRA
BRETAZENIL
SynDRA canonical compound SYN0005480 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GABRA5 |
| Mechanism of action | GABA benzodiazepine site receptor partial agonist |
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA5
- GABRA4
- GABRA6
- TSPO
Mechanisms of action (all sources)
- GABA benzodiazepine site receptor partial agonist
- TSPO MODULATOR
Drug classes
Cross-references
Synonyms
- RO 16-6028/000
- RO-166028000
- RO-F61816-6028/000
- Ro 16-6028
- UNII-OSZ0E9DGOJ
- Bretazenil [USAN:INN]
- 1-Bretazenil
- Bretazenilum [INN-Latin]
- OSZ0E9DGOJ
- BRN 4765855
- C19H20BrN3O3
- CHEMBL366947
- NCGC00160640-01
- DSSTox_RID_81493
- DSSTox_CID_26266
- DSSTox_GSID_46266
- tert-Butyl (S)-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo(1,5-a)pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylate
- Bretazenilum
- 9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid
- 9H-Imidazo(1,5-a)pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylic acid, 8-bro
- Ro-16-6028/000
- Ro-166028000
- DTXCID4026266
- RefChem:917541
- Ro-16-6028
- CAS-84379-13-5
- LWUDDYHYYNNIQI-ZDUSSCGKSA-N
- BRETAZENIL [INN]
- Bretazenil (USAN/INN)
- BRETAZENIL [USAN]
- Ro 16-6028; Ro 16-6028/000
- SCHEMBL124595
- GTPL4146
- orb1473105
- SCHEMBL29716315
- HMS3413P18
- HMS3677P18
- JDA37913
Look up BRETAZENIL in the interactive SynDRA portal →